Patent Yard Sign in
Canadian application, no grantCanada

Thiazole derivative

CA 2233611 A1 · Owner: Tominaga, Michiaki · Inventors: Tominaga, Michiaki; Nakaya, Kenji; Shinohara, Tomoichi

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A thiazole compound of formula (I), wherein T is lower alkylene; u is 0 or 1; R1 and R2 are the same or different and are each H or lower alkyl, etc.; R3 , is (1) or (2); R4 is H or lower alkanoyloxy-lower alkyl which shows , inhibitory activity or protein kinase C(PKC Ca2+/phospholipid-depending , serine/threonine protein phosphatase) and are useful as a protein kinase C , inhibitor.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 29, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 29, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 29, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 29, 1997
GrantedNo grant recorded
Term endedJuly 29, 2017
Patent numberCA 2233611 A1
Classification (IPC)C07D277/82 +2 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedJuly 29, 1997Term endedJuly 29, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.